Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 34, 2020 - Issue 23
230
Views
4
CrossRef citations to date
0
Altmetric
Research Articles

Two new bioactive lignans from leaves and twigs of Cleistanthus concinnus Croizat

, , , , &
Pages 3328-3334 | Received 06 Nov 2018, Accepted 07 Jan 2019, Published online: 05 Feb 2019

References

  • Cabanillas BJ, Le Lamer A-C, Castillo D, Arevalo J, Rojas R, Odonne G, Bourdy G, Moukarzel B, Sauvain M, Fabre N. 2010. Caffeic Acid Esters and Lignans from Piper sanguineispicum. J Nat Prod. 73:1884–1890.
  • Govindachari TR, Sathe SS, Viswanathan N, Pai BR, Srinivasan M. 1969. Chemical constituents of Cleistanthus collinus. Tetrahedron. 25:2815–2821.
  • Kumar CPP, Pande G, Shanmugam G. 1998. Cleistanthin B causes G1 arrest and induces apoptosis in mammalian cells. Apoptosis. 3:413–419.
  • Li Bingtao SD. 2008. Flora of China. Beijing: Science Press.
  • Liu Y, Young K, Rakotondraibe LH, Brodie PJ, Wiley JD, Cassera MB, Callmander MW, Rakotondrajaona R, Rakotobe E, Rasamison VE, et al. 2015. Antiproliferative compounds from Cleistanthus boivinianus from the Madagascar dry forest. J Nat Prod. 78:1543–1547.
  • McGarry EJ, Pegel KH, Phillips L, Waight ES. 1969. Cleistanthol, a novel diterpene from Cleistanthus schlechteri (Euphorbiaceae). J Chem Soc D. 1074.
  • Meenakshi J, Shanmugam G. 2000. Cleistanthin A, a diphyllin glycoside from Cleistanthus collinus, is cytotoxic to PHA-stimulated (proliferating) human lymphocytes. Drug Dev Res. 51:187–190.
  • Morais LCSL, Pachu CO, Santos VL, Barbosa-Filho JM. 1996. New lignan from Ocotea duckei. Fitoterapia. 67:557.
  • Parasuraman S, Raveendran R, Vijayakumar B, Velmurugan D, Balamurugan S. 2012. Molecular docking and ex vivo pharmacological evaluation of constituents of the leaves of Cleistanthus collinus (Roxb.) (Euphorbiaceae). Indian J Pharmacol. 44:197–203.
  • Pegel KH, Candy HA, Pakshong JM. 1970. Pimarane diterpenes from Cleistanthus schlchteri. J Chem Soc, C. 2536–2538.
  • Prabhakaran C, Kumar P, Panneerselvam N, Rajesh S, Shanmugam G. 1996. Cytotoxic and genotoxic effects of cleistanthin B in normal and tumour cells. Mutagenesis. 11:553–557.
  • Pradheepkumar CP, Shanmugam G. 1999. Anticancer potential of cleistanthin A isolated from the tropical plant Cleistanthus collinus. Oncol Res.11:225–232.
  • Ramesh C, Ravindranath N, Ram TS, Das B. 2003. Studies on phytochemicals - 42. Arylnaphthalide lignans from Cleistanthus collinus. Chem Pharm Bull.51:1299–1300.
  • Salimuzzaman Siddiqui FH, Sabira Begum, and Binas Siddiqlji. 1988. Oleanderol, a new pentacyclictriterpene from the leaves of Nerium oleander. J Nat Prod. 51:229–233.
  • Thanh V-T-T, Pham V-C, Nguyen H-H, Mai H-D-T, Minh H-N-T, Nguyen V-H, Litaudon M, Gueritte F, Chau V-M. 2011. Cleistanone: A triterpenoid from Cleistanthus indochinensis with a new carbon skeleton. Eur J Org Chem. 2011:4108–4111.
  • Trinh TTV, Pham VC, Doan TMH, Nguyen VH, Chau VM, Litaudon M, Gueritte F. 2014. Cytotoxic aryltetralin lignans from fruits of Cleistanthus indochinensis. Planta Med. 80:695–702.
  • Vijayakumar B, Parasuraman S, Raveendran R, Velmurugan D. 2014. Identification of natural inhibitors against angiotensin I converting enzyme for cardiac safety using induced fit docking and MM-GBSA studies. Pharmacogn Mag. 10:639–644.
  • Wang WS, Lan XC, Wu HB, Zhong YZ, Li J, Liu Y, Shao CC. 2012. Lignans from the flower buds of Magnolia liliflora Desr. Planta Med. 78:141–147.
  • Leong Y-W, Harrison LJ. 1999. (20R,23E)-Eupha-8,23-diene-3b,25-diol from Tripetalum cymosum. Phytochemistry. 50:849–857.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.